In contrast with advances in massively parallel DNA sequencing 1 , high-throughput protein analyses [2] [3] [4] are often limited by ensemble measurements, individual analyte purification and hence compromised quality and cost-effectiveness. Single-molecule protein detection using optical methods 5 is limited by the number of spectrally non-overlapping chromophores. Here we introduce a single-molecularinteraction sequencing (SMI-seq) technology for parallel protein interaction profiling leveraging single-molecule advantages. DNA barcodes are attached to proteins collectively via ribosome display 6 or individually via enzymatic conjugation. Barcoded proteins are assayed en masse in aqueous solution and subsequently immobilized in a polyacrylamide thin film to construct a random single-molecule array, where barcoding DNAs are amplified into in situ polymerase colonies (polonies) 7 and analysed by DNA sequencing. This method allows precise quantification of various proteins with a theoretical maximum array density of over one million polonies per square millimetre. Furthermore, protein interactions can be measured on the basis of the statistics of colocalized polonies arising from barcoding DNAs of interacting proteins. Two demanding applications, G-protein coupled receptor and antibody-binding profiling, are demonstrated. SMI-seq enables 'library versus library' screening in a one-pot assay, simultaneously interrogating molecular binding affinity and specificity.
In contrast with advances in massively parallel DNA sequencing 1 , high-throughput protein analyses [2] [3] [4] are often limited by ensemble measurements, individual analyte purification and hence compromised quality and cost-effectiveness. Single-molecule protein detection using optical methods 5 is limited by the number of spectrally non-overlapping chromophores. Here we introduce a single-molecularinteraction sequencing (SMI-seq) technology for parallel protein interaction profiling leveraging single-molecule advantages. DNA barcodes are attached to proteins collectively via ribosome display 6 or individually via enzymatic conjugation. Barcoded proteins are assayed en masse in aqueous solution and subsequently immobilized in a polyacrylamide thin film to construct a random single-molecule array, where barcoding DNAs are amplified into in situ polymerase colonies (polonies) 7 and analysed by DNA sequencing. This method allows precise quantification of various proteins with a theoretical maximum array density of over one million polonies per square millimetre. Furthermore, protein interactions can be measured on the basis of the statistics of colocalized polonies arising from barcoding DNAs of interacting proteins. Two demanding applications, G-protein coupled receptor and antibody-binding profiling, are demonstrated. SMI-seq enables 'library versus library' screening in a one-pot assay, simultaneously interrogating molecular binding affinity and specificity.
To analyse proteins in a massively parallel single-molecule format, we generated proteins that are molecularly coupled to a DNA bearing a barcoding sequence. One barcoding approach is to translate and display proteins on protein-ribosome-messenger-RNA-complementary-DNA (PRMC) complexes in vitro, in which the cDNA contains a synthetic barcode at the 59 end of protein open reading frames (ORFs) (Fig. 1a) . Specifically, the ribosome display was performed by using mRNA-cDNA hybrids as templates and an in vitro translation (IVT) system reconstituted with purified components 8 that was shown to stabilize PRMC complexes (Extended Data Fig. 1 ). PRMC complexes bearing full-length proteins of interest were enriched by Flag-tag affinity purification. Notably, this approach is applicable to a library of proteins of various sizes and size-related biases during decoding can be avoided by using uniformly sized barcoding DNAs. Alternatively, some proteins that can only be functionally expressed in vivo require individual barcoding. Thus, fusion proteins were constructed with an engineered enzyme tag, HaloTag 9 , which mediates an efficient covalent conjugation to a HaloTag-ligandmodified double-stranded DNA (Fig. 1b) . Our method is adaptable to a microtitre plate format for automated parallel protein production (Extended Data Fig. 2) .
A complex mixture of barcoded proteins can be identified and quantified by in situ sequencing of their barcodes (Fig. 2a) . The proteins were immobilized into an ultrathin layer of crosslinked polyacrylamide gel attached to a microscopic slide, and their barcoding DNAs bearing a 59-acrydite modification ( Fig. 1) were covalently crosslinked to the gel matrix to prevent template drifting (Extended Data Fig. 3) . A solid-phase PCR, with two gel-anchored primers, was performed according to an adapted isothermal bridge amplification protocol 10 in an assembled flow cell. This amplification showed a high efficiency of ,80% barcode detection (Extended Data Fig. 4a) , and resulted in polonies of ,1 mm diameter (Fig. 2b) , similar to the clusters generated on an Illumina platform 10 . Polonies were identified by hybridization with fluorescent probes, single-base extension (SBE) or ligation-based sequencing 11 . To test the accuracy of our method, we selected nine immunoglobulin and non-immunoglobulin binding proteins and three antigens (for example, human, bacterial and viral proteins) of a molecular weight ranging from 3.4 to 120 kDa (Extended Data Table 1 ). Mixed PRMC complexes were prepared in six barcoded dilutions, with concentrations spanning six orders of magnitude, pooled together and subjected to the single-molecule quantification. Barcode detection efficiencies of different proteins were found to be almost identical at various concentrations (Extended Data Fig. 4 ). The in situ single-molecule quantification can avoid PCR amplification bias 12 and shows high reproducibility; the Pearson correlation coefficient r was above 0.99 when over 1,000 protein polonies were detected (Fig. 2c) . Because proteins were highly diluted (at less than picomolar concentrations) before array deposition, protein monomers should be the predominant form.
Interacting barcoded proteins can be indirectly detected by joining their barcoding DNAs via ligation 13, 14 be possible if barcoding DNAs of interacting proteins can be amplified into colocalized polonies. To test this, we generated DsRed, which naturally forms a tetramer, with monomers each bearing one of two different barcodes. To avoid dissociation of any complexes during the array analysis, we crosslinked them with an amine-reactive crosslinker, bis-N-succinimidyl-(pentaethylene glycol) ester (BS(PEG) 5 ). The crosslinking was shown to be efficient due to the presence of a lysine-rich TolA spacer domain ( Fig. 1a and Extended Data Fig. 5 ). It is evident that barcoding DNAs of the colocalized monomers (DsRed a and DsRed b ) were co-amplified into overlapping polonies (Fig. 3a) , providing a solid basis for further applications.
Unlike other methods that only detect affinity-enriched proteins (for example, PLATO 16 ), our approach simultaneously counts polonies of both unbound and bound proteins in a single solution. Thus, we sought to determine if it can provide a measure of protein binding affinities. We chose a model system, the GTP-dependent binding of human HRas (Ras) to Ras-binding domain of c-Raf-1 (Raf-RBD) 17 . A Raf-RBD polony colocalization ratio-the percentage of Raf-RBD polonies colocalized with Ras polonies-was measured for wild-type Ras and Raf-RBD and eight Raf-RBD mutants; the Ras protein concentration was titrated over three orders of magnitude (Fig. 3b) . Although the colocalization ratio is dependent on protein concentration and crosslinking efficiency and can be affected by experimental variables (protein quality, crosslinking conditions, polony array density, etc.), all the proteins within a single assay are under the same reaction conditions. Given a similar proportion of active protein and crosslinking efficiency, polony colocalization ratios could be correlated with ratios of bound proteins at equilibrium and thus their binding affinities. To test this, the colocalization ratios were plotted against previously reported dissociation constants (K d values) ranging from nanomolar to micromolar values 18, 19 ( Fig. 3b and Supplementary Table 1) , and fitted by using a one-sitespecific binding model (dashed curves). The fitted and observed average colocalization ratios show relatively high agreement (r . 0.96), except for the A85K mutant which displayed significantly lower experimental values than predicted by the model, probably owing to the disruption of Lys 85-mediated interactions 19 by the crosslinking. Therefore, this method could be useful for high-throughput screening of protein binding affinities.
As a first high-throughput screening application, we investigated small molecule-mediated protein-protein interactions. An advantage of our method over traditional solid-phase techniques such as protein microarrays 3 is that we store and assay proteins in an aqueous solution. To exploit this, we decided to address the challenges in screening G-protein coupled receptors (GPCRs), the largest membrane protein family and premier drug targets 20 . Current GPCR-ligand screening techniques mainly rely on cell-based assays 21 , which are subject to limitations such as the heterogeneous nature of the samples, the presence of other cellular components that can cause false positives or negatives, and limited miniaturization and multiplexing capability (for example, one receptor per Table 1 ). Fitting equation, R~R max |P= K d zP ð Þ , where R is the predicted Raf-RBD polony colocalization ratio, R max is the maximum polony colocalization ratio when Raf-RBD is saturated by Ras, and P is the Ras concentration. WT, wild type. c, Schematic of multiplex GPCR screening and compound profiling by the binding assay of mixed barcoded GPCRs with barcoded b-arr2. d, Comparison of b-arr2 binding to isoproterenol-activated b 2 -adrenergic receptor with or without GRK2-mediated phosphorylation. Titration data of b-arr2 were fitted by the one-site-specific model using GraphPad Prism 6. e, Parallel GPCR binding profiling. Data represent mean values of 50 measurements; error bars, 95% CL, highlighted in red for agonists (refer to Supplementary Table 2 ). **P , 0.01, ***P , 0.001, one-tailed paired Student's t-test.
LETTER RESEARCH assay). To prepare a homogeneous single-molecule GPCR sample compatible with our approach, receptors were stabilized in phospholipid bilayer nanodiscs 22 by assembling detergent-solubilized GPCRs, phospholipids and a membrane scaffold protein, MSP1E3D1, into GPCRnanodisc complexes 23, 24 . GPCR activation upon ligand binding can be functionally assessed by b-arrestin binding to activated receptors, which is a G-protein-independent assay applicable to almost all GPCRs, including orphan receptors 25 . A compound library can be screened in multi-well plates, and in each well one compound is assayed with many barcoded GPCRs and a b-arrestin-2 (b-arr2) protein bearing a well-position-associated barcode (Fig. 3c) . All the samples were pooled and deposited on one slide, and GPCR agonists were detected by measuring GPCR polony colocalization with corresponding b-arr2 polonies. Our efforts to obtain functional GPCRs using IVT systems were not successful, so they were expressed in baculovirus-infected insect cells, purified in nanodiscs and individually barcoded (Fig. 1b) . To establish assay conditions, we examined b-arr2 binding to an agonist (isoproterenol)-saturated b 2 -adrenergic receptor (ADRB2), with and without GPCR kinase 2 (GRK2)-mediated receptor phosphorylation and under varied b-arr2 protein concentrations (Fig. 3d) . The colocalization ratios were measured at 50 imaging positions on the array for statistical analysis. As expected, coupling the receptor phosphorylation to the assay improves the b-arr2 binding; 3-to 11-fold increases (largest P 5 0.002) of the average colocalization ratios after phosphorylation were observed. The fitting of b-arr2 titration data for the phosphorylated receptor yielded an apparent K d of 0.95 nM, which is close to the K d of 0.23 nM obtained from traditional binding assays using radiolabelled b-arr2 26 . To test the screening performance, we assayed three GPCRs, ADRB2, M1 and M2 muscarinic acetylcholine receptors (CHRM1 and CHRM2), with six compounds including full, partial, subtype-selective and nonselective agonists and two antagonists ( Fig. 3e and Supplementary Table 2 ). The colocalization statistical analysis based on measurements of ,13,000-17,000 polonies for each receptor precisely identified the full agonists (isoproterenol and carbachol) from the others (largest P , 2.7 3 10
210
). Moreover, different types of agonists can be distinguished by comparing their polony colocalization ratios, for example, the full and partial agonists of ADRB2 (isoproterenol and pindolol, respectively; P , 0.004), and the orthosteric and allosteric agonists of CHRM1 (carbachol and xanomeline, respectively; P , 3 3 10
26
). Thus, our method could allow parallel GPCR screening and compound profiling.
An intriguing feature of this approach is the ability to screen two barcoded libraries in a single binding assay. Established techniques (for example, yeast two-hybrid systems 2 ) for library versus library screening are cell-based and require pairing both genes from two libraries to identify positive clones by performing individual PCR reactions 27 . To demonstrate this capability, we prototyped a test of a demanding application, the binding profiling of an antibody repertoire. The screening of natural or semisynthetic monoclonal antibody libraries essentially includes binding affinity selection and specificity profiling, which have to be conducted separately with current techniques. The traditional specificity profiling is costly, usually requiring at least one protein chip for a single antibody test 28 , and thus has only been commercially applied to therapeutic antibodies. However, both processes could be integrated on our platform by screening an antibody library with a target-protein library.
Specifically, we performed a one-pot assay containing 200 ribosomedisplayed single-chain variable fragments (scFvs) and 55 human proteins including cytokines, growth factors and receptors synthesized in vitro (Extended Data Table 2 ). Twenty scFvs were derived by random mutagenesis from each of ten scFvs, the genes of which were previously synthesized from a programmable DNA microchip 29 . We sequenced ,0.64 million polonies and measured the colocalization ratios for 11,000 scFv-target protein (probe) pairs at 100 imaging positions (Fig. 4a and  Supplementary Table 3) . Of 200 scFvs, 147 were found with the highest colocalization ratios, 95 of which are significantly above the second highest (P , 0.05), and thus the highest specificity, to their predicted targets; the others failed probably because the construction of scFv fragments and mutations inhibit target binding. Substantial cross-reactivity can be sensitively detected, for example, 3,474 scFv-probe pairs showed tenfold higher polony colocalization than random distribution (P , 0.01). scFv mutants of a same scFv, grouped by their numbers, exhibit similar but not identical binding patterns to the probes. Next, we confirmed the results of 40 scFv-probe pairs by individual immunoprecipitation assays and the colocalization statistics were consistent with relative fluorescence intensities of the probe protein bands (Fig. 4b) . Moreover, to further assess multiplexing potential, we developed a mathematical model that integrated parameters including K d values of protein-probe complexes to be detected and numbers of proteins and probes that can be assayed simultaneously (Supplementary Notes). The model suggests that tens of thousands of proteins and probes can be quantifiably analysed within a single assay.
The protein barcoding requirement imposes limitations on SMIseq. First, it cannot directly analyse proteins from biological samples. However, non-barcoded proteins can be detected in a similar fashion by using barcoded antibodies or aptamers as part of a proximity ligation assay 13, 14 . In addition, PRMC complexes are susceptible to nuclease contamination, thus limiting the choice of IVT systems. Finally, barcoding DNA can non-specifically bind to proteins bearing nucleic-acid-binding domains. Although in the present study DNA templates were individually barcoded, a large library can be prepared by introducing millions of chip-synthesized 29 or random barcoding sequences to an open reading frame (ORF) library by a single PCR reaction and later matching them to ORF sequences by next-generation sequencing. SMI-seq enables single-molecule counting of proteins and complexes in situ, fundamentally improving sensitivity, accuracy and multiplexity (Extended Data  Table 3 and Supplementary Discussion), and thus the demonstrated applications are difficult or impossible to perform with other highthroughput techniques (for example, PLATO). It is readily adaptable to industrial next-generation sequencing platforms and translated into Table 3) . ScFvs sharing the same origins were grouped by their numbers (Extended Data Table 2 ). b, Correlation between the polony colocalization statistics and the scFv immunoprecipitation results. For the immunoprecipitation assay, selected scFvs were fused to a C-terminal streptavidin binding peptide tag and bound to streptavidin magnetic beads to pull down human protein probes bearing a HaloTag, which can be labelled by Halo-tetramethylrhodamine (TMR) for fluorescent gel imaging. Error bars, 95% CL, highlighted in red for specific scFv-probe binding. ***P , 0.001, one-tailed paired Student's t-test.
RESEARCH LETTER many applications. In addition to natural and recombinant proteins, it will be applicable to de novo proteins (for example, with unnatural amino acids or modifications), nucleic acids and barcoded small molecules 30 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
DNA construction. Protein coding sequences were synthesized by Genewiz and Integrated DNA Technologies, PCR amplified from plasmids or genomic DNA, or transferred from Gateway-adapted human ORF clones 31 (refer to Supplementary  Table 4 for DNA sources, sequences and construction methods) and inserted into a multiple cloning site or Gateway recombination sites of expression vectors (refer to Supplementary Fig. 1 for plasmid construction and Supplementary Table 5 for plasmid and primer sequences) for in vitro or in vivo protein expression. Ribosome-display-based protein barcoding. To barcode protein libraries of relatively small size (# 200 in this work), synthetic barcoding sequences were introduced to DNA templates via individual PCRs. Barcoded linear DNA templates were pooled and transcribed in vitro using a HiScribe T7 kit (New England Biolabs). To generate mRNA-cDNA hybrids, cDNAs were synthesized by incubating ,0.10 mM mRNA, 1 mM 59-acrydite and desthiobiotin-modified primer, 0.5 mM of each deoxynucleotide triphosphate (dNTP), 10 U ml 21 SuperScript III, 2 U ml 21 RNaseOUT (Invitrogen) and 5 mM dithiothreitol (DTT) in a buffer (50 mM Tris-HCl, pH 8.3, 75 mM KCl, and 5 mM MgCl 2 ) at 50 uC for 30 min. Synthesized mRNA-cDNA hybrids serve as templates for ribosome display using a PURExpress D ribosome kit (New England Biolabs). Typically, a 100 ml IVT reaction with ,0.40 mM mRNAcDNA hybrids and ,0.30 mM ribosome was incubated at 37 uC for 30 min, quenched by addition of 100 ml ice-cold buffer HKM (50 mM HEPES, pH 7.0, 250 mM KOAc, 25 mM Mg(OAc) 2 , 0.25 U ml 21 RNasin (Promega), 0.5 mg ml 21 chloramphenicol, 5 mM 2-mercaptoethanol and 0.1% (v/v) Tween 20) and centrifuged (14,000g, 4 uC) for 10 min to remove insoluble components. PRMC complexes, always kept on ice or in a cold room, were subjected to two-step Flag tag and desthiobiotin tag affinity purification to enrich full-length and barcoded target proteins. In brief, proteins were sequentially purified using anti-Flag M2 magnetic beads (Sigma-Aldrich) and streptavidin-coated magnetic beads (Dynabeads M-270 Streptavidin, Life Technologies) blocked with the buffer HKM supplemented with 0.1 mg ml 21 yeast transfer RNA and 10 mg ml 21 BSA. The bound proteins were eluted with the buffer HKM containing 0.1 mg ml 21 Flag peptide or 5 mM biotin, and their barcoding DNAs were quantified by real-time PCR. Protein expression and purification and HaloTag-based barcoding. His-tagged HaloTag-TolA, HaloTag-DsRed-TolA, HaloTag-mCherry-TolA, Ras-TolA-HaloTag and b-arr2-TolA-HaloTag were expressed in E. coli or using an E. coli IVT system. Proteins were expressed in an OverExpress C41(DE3) strain (Lucigen) with 1 mM isopropyl-b-D-galactopyranoside (IPTG) induction at 30 uC for 8-10 h, and purified using immobilized metal affinity chromatography (IMAC) at 4 uC. In brief, harvested cells were resuspended in 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 10 mM imidazole and 20% glycerol, and disrupted by French press. Supernatants of cell lysates were loaded on a 5 ml HisTrap column (GE Healthcare) and nonspecifically bound components were washed off with 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 20 mM imidazole and 10% glycerol. Proteins were eluted with 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 250 mM imidazole and 10% glycerol, concentrated with Amicon Ultra-15 centrifugal filter units (Millipore), buffer exchanged to a storage buffer (50 mM HEPES, pH 7.0, 150 mM KOAc and 20% glycerol) using a PD10 desalting column (GE Healthcare), flash frozen in 100-500 ml aliquots by liquid N 2 and stored at 280 uC. Relatively small amounts of proteins were typically synthesized in an E. coli crude extract (RTS 100 E. coli HY, 5 PRIME) at 30 uC for ,4 h, and similarly purified with His-tag magnetic beads (Dynabeads His-tag, Life Technologies).
Human ADRB2, CHRM1 and CHRM2 were expressed in baculovirus-infected Sf9 cells (Life Technologies), solubilized with detergents as previously described 32, 33 , and assembled into GPCR-nanodisc complexes followed by affinity purification 34 . In brief, GPCR genes were synthesized and inserted into a pBac-NFlagHA vector for the expression of the fusion proteins bearing amino-terminal Flag and hemagglutinin (HA) epitope tags and a HaloTag domain. Cells were harvested at 2 days after transfection, homogenized in a 50 mM Tris-HCl, pH 7.4, 50 mM NaCl and 1 mM EDTA with a protease inhibitor cocktail (Roche), and centrifuged to collect membrane fractions. The membranes were solubilized in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM CaCl 2 , 5 mM MgCl 2 , 2 mM EDTA, 10% glycerol, 1% N-dodecylb-D-maltopyranoside (DDM) and a protease inhibitor cocktail (Set III, EMD Biosciences), and centrifuged at 15,000g for 15 min; the supernatants were subjected to a bicinchoninic acid assay (Thermo Scientific) to determine the protein concentration. The nanodiscs were assembled by incubating 90 mM MSP1E3D1 (SigmaAldrich), 8 mM POPC, 40 mM DDM and 180 mg total membrane protein in 50 mM Tris pH 7.4, 150 mM NaCl, 5 mM CaCl 2 , 5 mM MgCl 2 , 2 mM EDTA and 2% glycerol on ice for 45 min, followed by removal of the detergent using Bio-Beads SM-2 (Bio-Rad) 34 . GPCR-nanodisc complexes were bound to anti-Flag M1 agarose resin (Sigma-Aldrich) and eluted with a conjugation buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 2 mM EDTA and 5% glycerol) in the presence of 0.2 mg ml 21 Flag peptide.
Human proteins were synthesized in vitro with a human IVT kit (Thermo Scientific). Proteins were individually translated at 30 uC for 2 h and purified with the anti-Flag M2 or His-tag magnetic beads. Membrane proteins were stabilized by addition of preassembled nanodiscs (2 ml MembraneMax reagent per 50 ml reaction, Life Technologies). To semi-quantifiably analyse HaloTag fusion proteins, their HaloTag domains were covalently labelled with a fluorescent reporter Halo-TMR (Promega) and analysed by SDS-PAGE and the fluorescent gel imaging with a Typhoon Trio Imager (GE Healthcare).
Barcoding DNAs of 220 bp in length were prepared in parallel by adding barcoding sequences via PCR with a universal template and barcoded primers, and introducing the modifications by a secondary PCR with the modified primers (Integrated DNA Technologies). A HaloTag ligand was conjugated to the primer by incubating 100 mM amino-modified oligonucleotide and 10 mM succinimidyl ester (O4) ligand (Promega) in 50 mM Na 2 HPO 4 , pH 8.0, 150 mM NaCl and 50% formamide at room temperature for 1 h; the modified oligonucleotide was purified by reverse-phase high-performance liquid chromatography using a Zorbax Eclipse XDB-C18 column (5 mm, 9.4 3 250 mm, Agilent Technologies) and an elution gradient of 5-70% CH 3 CN/H 2 O (0.1 M triethylammonium acetate). To generate protein-DNA conjugates, we typically incubated ,0.5-2 mM modified barcoding DNAs and ,2-5 mM HaloTag-labelled proteins in the conjugation buffer with gentle shaking at room temperature for 2-4 h; the conjugates were purified with the anti-Flag M2 or His-tag magnetic beads and the streptavidin magnetic beads. Barcoded proteins were eluted in assay buffers (see below) in the presence of 5 mM biotin. Ras-Raf-RBD binding assay. Prior to the barcoding, the E. coli-expressed and purified Ras protein was saturated with a non-hydrolysable GTP analogue, Gpp(NH)p, by EDTA-enhanced nucleotide exchange as previously described 35 . Mixed wild-type and mutant Raf-RBD (2 nM) displayed on PRMC complexes were incubated with different concentrations of barcoded Ras in 50 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 0.5 mM DTT, 0.1% (v/v) Tween 20 and 0.5 mM Gpp(NH)p for 1 h. After reaching equilibrium, Ras-Raf-RBD complexes were crosslinked with 0.5 mM BS(PEG) 5 at 4 uC for 1 h. The reaction was quenched by adding Tris-HCl (pH 8.0) to a final concentration of 50 mM. As unbound Ras can contribute to random Raf-RBD polony colocalization, it was removed by HA-tag affinity purification to enrich HA-tagged Raf-RBD and bound Ras. Thus, the samples were incubated with anti-HA magnetic beads (Thermo Scientific) at 4 uC for ,2 h and eluted with an array deposition buffer (20 mM HEPES, pH 7.0, 50 mM KOAc, 6 mM Mg(OAc) 2 , 0.25 U ml 21 RNasin (Promega) and 0.1% Tween 20) in the presence of 2 mg ml
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HA peptide. GPCR profiling assay. Mixed barcoded GPCRs were assayed with 100 mM alprenolol, pindolol, isoproterenol, atropine and carbachol (Sigma-Aldrich) and 100 nM xanomeline (Tocris Bioscience). The GPCR-b-arr2 binding assay was performed by adding a ligand to ,1 nM GPCR-nanodisc complexes in 20 mM HEPES, pH 7.5, 50 mM KOAc, 2 mM EDTA and 5 mM MgCl 2 , followed by addition of 10 nM GRK2 (Life Technologies), 0.1 mM ATP, 10 nM G protein b 1 c 2 subunits (KeraFAST) and 5 nM barcoded b-arr2 to a total volume of 25 ml. Compounds were assayed in parallel, and reactions were incubated at 30 uC for 30 min followed by the crosslinking and the HA-tag affinity purification described above. Proteins from multiple wells were pooled and analysed on a single array. ScFv binding profiling and immunoprecipitation assay. To diversify scFvs, errorprone PCR was performed for the ten scFv genes by using a random mutagenesis kit (Clontech Laboratories) under the condition of 3.5 mutations per 1,000 bp. Twenty mutants for each scFv were randomly picked and barcoded to construct a scFvs library. Ribosome display of the scFv library was specifically performed with the PURExpress D ribosome kit supplemented with disulphide bond enhancers (New England Biolabs, 4 ml of the enhancer 1 and 2 per 100 ml reaction). The binding assay was performed by incubating 200 scFvs (,5.5 nM in total) and 55 barcoded human proteins (,1.8 mM in total) in an assay buffer (50 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 and 0.1% (v/v) Tween 20) at 4 uC for 4 h. Similarly as above, samples were subjected to the crosslinking and the HA-tag affinity purification. For the immunoprecipitation assay, selected scFv genes were subcloned into pEco-CSBP to express scFv fusions bearing a C-terminal streptavidin binding peptide tag. Proteins were synthesized in vitro using a PURExpress IVT kit supplemented with the disulphide bond enhancers. In each binding assay, a 10 ml IVT reaction typically containing 0.1-0.4 mM translated scFvs was incubated with 2 ml human proteins (4.6-9.5 nM) labelled by Halo-TMR in the assay buffer at 4 uC for 4 h. Bound human proteins were pulled down with the streptavidin magnetic beads and analysed by SDS-PAGE and the fluorescent gel imaging. Array deposition. Barcoded proteins were diluted with the deposition buffer to a tenfold deposition concentration between 0.1 and 1 nM. Because the presence of oxygen can inhibit the gel polymerization, a gel-casting solution (6.66% acrylamide/ bis-acrylamide (19:1, molecular grade, Ambion) and two 59-acrydite-modified bridge amplification primers (278 mM each) in the deposition buffer) were degassed with RESEARCH LETTER argon and mixed with diluted proteins by a 9:1 volume ratio in an anaerobic chamber (Coy Lab). To form a gel layer of less than 5-mm thickness, $ 20 ml gel-casting mix, immediately after addition of 0.1% (v/v) TEMED and 0.05% (w/v) ammonium persulfate, was applied to a glass slide surface pretreated with Bind-Silane (GE Healthcare) 7, 36 , and a coverslip was placed on the top of the liquid and tightly pressed to form a liquid layer evenly spreading over the glass surface. The gel was polymerized in the chamber for 4 h. After removal of the coverslip, the slide was washed with Milli-Q H 2 O and dried by a quick spin. Polony amplification, linearization and blocking. A protein-deposited slide was assembled in a FC 81 transmission flow cell containing a 1.85-mm-thick polycarbonate flow channel (BioSurface Technologies) for polony amplification, linearization and blocking. Flow cell components including the channel, a coverslip and tubing were cleaned by sonication in 5% Contrad 70 and Milli-Q H 2 O, and air dried in an AirClean PCR hood. Prior to the amplification, samples containing mRNA2cDNA hybrids can be digested with 10 U ml 21 RNase H (New England Biolabs) in 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 and 0.1% (v/v) Triton X-100 at 37 uC for 20 min. Polony amplification, linearization and blocking were performed by using an adapted cluster generation protocols 10 . In brief, immobilized barcoding DNAs were subjected to 32-35 cycles of isothermal bridge amplification at 60 uC. For each cycle, the flow cell was washed with deionized formamide (Ambion) and an amplification buffer (20 mM Tris-HCl, pH 8.8, 10 mM ammonium sulphate, 2 mM magnesium sulphate, 0.1% (v/v) Triton X-100, 1.3% (v/v) dimethylsulphoxide and 2 M betaine) and incubated with 200 mM dNTPs and 80 U ml 21 Bst polymerase (New England Biolabs) in the amplification buffer for 5 min. Resulted double-stranded polonies were linearized by adding 10 U ml 21 USER enzyme (New England Biolabs) in a linearization buffer (20 mM Tris-HCl, pH 8.8, 10 mM KCl, 10 mM ammonium sulphate, 2 mM magnesium sulphate and 0.1% (v/v) Triton X-100) followed by incubating the flow cell at 37 uC for 1 h. Excised strands were eluted with a wash buffer W1 (1 3 SSC and 70% formamide). Exposed 39-OH ends of polonies and primers were blocked by adding 250 U ml 21 terminal transferase (New England Biolabs) and 10 mM ddNTPs in a blocking buffer (20 mM Tris-acetate, pH 7.9, 50 mM KOAc, 10 mM Mg(OAc) 2 and 0.25 mM CoCl 2 ) followed by incubating the flow cell at 37 uC for 10 min. DNA sequencing. Linearized and 39-OH blocked polonies were analysed by hybridization with fluorescently labelled oligonucleotides, SBE or sequencing-byligation as previously described 11, 36 . The assays can be performed within the flow cell or a gasket chamber assembled with the polony slide taken out of the flow cell and a microarray gasket slide (Agilent Technologies). Polonies were probed with oligonucleotides or ddNTPs (PerkinElmer) labelled by fluorescein/FAM, Cy3/Ty563 or Cy5/Ty665 and subjected to three-colour fluorescence imaging. In brief, the hybridization was performed by incubating polonies with oligonucleotides (2 mM each) in a hybridization buffer (5 3 SSC and 0.1% (v/v) Tween 20) at 60 uC for 10 min followed by decreasing the temperature to 40 uC and washing off unbound oligonucleotides with a wash buffer W2 (0.3 3 SSC and 0.1% (v/v) Tween 20). The SBE was performed by incubating primer-bound polonies with fluorescently labelled ddNTPs (1 mM each) and 0.32 U ml 21 Thermo Sequenase (GE Healthcare) in 26 mM Tris-HCl, pH 9.5, 6.5 mM MgCl 2 and 0.05% (v/v) Tween 20 at 60 uC for 5 min, followed by washing off excess ddNTPs with the wash buffer W2. For each sequencingby-ligation cycle, polonies were hybridized to a sequencing primer and probed with a query oligonucleotide set (fluorescent nonamers, 2 mM each subpool) in a ligation buffer (50 mM Tris-HCl, pH 7.6, 10 mM MgCl 2 , 1 mM ATP and 5 mM DTT) in the presence of 30 U ml 21 T4 DNA ligase (Enzymatics). The ligation was incubated at room temperature for 20 min followed by increasing the temperature and maintaining it at 35 uC for 40 min. Prior to a next cycle, hybridized primers were stripped with the buffer W1 at 60 uC. To facilitate the deconvolution of colocalized polonies from two protein libraries, each library was separately sequenced using a different sequencing primer. Image acquisition, processing and base calling. Fluorescence imaging was conducted with a Leica AM TIRF MC system including a DMI6000 B inverted microscope, a motorized scanning stage and a Hamamatsu C9100-02 electron multiplying CCD camera (1,000 3 1,000 pixels, Hamamatsu Photonics). Polony images were acquired under an epi-illumination mode by using a 320 (HCX PL Fluotar L, N.A. 0.40, Leica) or 340 objective (HCX PL APO, N.A. 0.85, Leica) and from three channels (fluorescein, Cy3 and Cy5) using 488, 561 and 635 nm lasers and excitationemission filter pairs (490/20-525/50, 552/24-605/65 and 635/10-720/60, respectively). Raw images were exported by LAS AF Lite software (Leica) and processed using ImageJ and MATLAB (R2011a) scripts to remove background fluorescence and exclude small-size impurities and large-scale structures. Image analyses and base calling were conducted similarly as previously described 11 . In brief, MATLAB scripts were applied to identify polony coordinates by finding local maxima or weighted centroids, construct a reference image containing all detected polonies by superimposing images taken in the first cycle, and then align images from later cycles to the reference image. Thus, a set of fluorescence values for each acquisition cycle as well as the coordinates were obtained for polony identification and the colocalization analysis. No more than five sequencing cycles were required to analyse each library used in this work. Colocalization analysis and statistics. To align reference images for protein and probe libraries, polonies were hybridized with both sequencing primers labelled by Cy3 or Cy5, and then their images were superimposed to generate a cross-library reference. MATLAB scripts calculated the offset of reference images generated from two sequencing rounds, measured distances between all polony positions identified from the two libraries, and compared them to a defined threshold to determine the colocalization. We considered a polony exclusion effect usually observed for competitive co-amplification of colocalized templates 37, 38 , and set an optimized threshold distance to be 0.7 mm. Total and colocalized polony numbers were computed for each paired polony species at each imaging position. Colocalization statistics were calculated using Student's t-tests based on measurements at all imaged positions. In addition, a pair cross-correlation function statistic 39 was applied to analyse polony colocalization patterns (Supplementary Notes).
